Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PYROXD2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | RAB3IL1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | RBSN | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | UQCRC1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | ST20 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | LINC00694 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | SIGLEC9 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | UGT2B7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | RP11-552F3.12 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |